Pastāsti draugiem par šo preci:
Target Validation in Drug Discovery Dillon
Do you have a profile? Pierakstīties
Saņemiet paziņojumus par jauniem Dillon izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
| Mediji | Grāmatas Hardcover Book (Grāmata ar cieto muguriņu un vāku) |
| Izlaists | 2006. gada 1. septembris |
| ISBN13 | 9780123693938 |
| Izdevēji | Elsevier Science Publishing Co Inc |
| Lapas | 296 |
| Izmēri | 184 × 260 × 24 mm · 820 g |
| Redaktors | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
| Redaktors | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
Vairāk no Dillon
Rādīt visu
Vairāk no tā paša izdevēja
Skatīt visus Dillon ( piem., Book , CD , LP , Paperback Book un Hardcover Book )